Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 6, 1999, Pages 675-683

  Fujiki, Misae ^a   Shinbori, Toshifumi ^a,b   Suga, Moritaka ^a   Miyakawa, Hisako ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; STAPHYLOCOCCUS;

CHEMOKINE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; PREDNISOLONE; TACROLIMUS;

ANIMAL; ARTICLE; AUTOIMMUNITY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG; LUNG ALVEOLUS; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; SPLEEN; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; DISEASE MODELS, ANIMAL; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTES; MACROPHAGES; MICE; MICE, SCID; NEUTROPHILS; PREDNISOLONE; PULMONARY ALVEOLI; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES; TACROLIMUS;

EID: 0033257448     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.6.3498     Document Type: Article

References (37)

1. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35.
2. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 24:705-711.
3. Paliard, X., S. G. West, J. A. Lafferty, J. R. Clements, J. W. Kappler, P. Marrack, and B. L. Kotzin. 1991. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 25:325-329.
4. Conrad, B., E. Weidmann, G. Trucco, W. A. Rudert, R. Behboo, C. Ricordi, H. Rodriquez-Rilo, D. Finegold, and M. Trucco. 1994. Evidence for superantigen involvement in insulin-dependent diabetes aetiology. Nature 371:351-355.
5. Leung, D. Y., J. B. Travers, R. Giorrno, D. A. Norris, R. Skinner, J. Aelion, L. V. Kazemi, M. H. Kim, A. E. Trumble, M. Kotb, and P. M. Schlievert. 1995. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest. 96:2106-2112.
6. Lynch, J. P. III, and G. W. Hunninghake. 1992. Pulmonary complications of collagen vascular disease. Annu. Rev. Med. 43:17-35.
7. Nagai, S., and T. Izumi. 1997. Immunopathology of collagen vascular disease. Curr. Opin. Pulm. Med. 3:356-360.
8. Shinbori, T., M. Matsuki, M. Suga, K. Kakimoto, and M. Ando. 1996. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell. Immunol. 174: 129-137.
9. Watters, L. C., M. I. Schwarz, R. M. Cherniack, J. A. Waldron, T. L. Dunn, R. E. Stanford, and T. E. King. 1987. Idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 135:696-704.
10. Apertini, F., J. D. Aubert, and A. Leimgruber. 1996. The potential of bronchoalveolar lavage in the prognosis and treatment of connective-vascular disease. Clin. Exp. Rheumatol. 14:681-688.
11. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-756.
12. Kerppola, T. K., D. Luk, and T. Curran. 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:3782-3791.
13. Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okumura, M. Kohsaka, H. Aoki, and H. Imanaka. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces: I. Fermentation, isolation, and physico-chemical characteristics. J. Antibiot. (Tokyo) 40:1249-1255.
14. Kino, T., H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Yajima, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and T. Ochiai. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces: II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo) 40:1256-1265.
15. Yoshikai, Y., H. Kidokoro, K. Kimura, Y. Aoki, M. Makino, and K. Hiromatsu. 1997. Clonal expansion of superantigen-reactive T cells is resistant to FK506 in mice with AIDS. J. Virol. 71:746-749.
16. Arreaza, G., N. Yoshikawa, T. Mukuta, E. Resetkova, A. Barsuk, M. Nishikawa, C. Muallim, N. Miller, C. Jamieson, and R. Volpe. 1995. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J. Clin. Endocrinol. Metab. 80:3724-3731.
17. + T cells in staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065-1070.
18. Hathcook, K. S. 1992. T cell enrichment by nonadherence to nyron. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, editors. John Wiley and Sons, New York. 3.2.1-3.2.4.
19. Anderson, J., S. Nagy, C. G. Groth, and U. Andersson. 1992. Effect of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell. Immunology 75:136-142.
20. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
21. Edwards, C. K., III, T. Zhou, J. Zhang, T. J. Baker, M. De, R. E. Long, D. R. Borcherding, T. L. Bowlin, H. Bluethmann, and J. D. Mountz. 1996. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-α. J. Immunol. 157:1758-1772.
22. Nash, J. R., P. J. McLaughlin, D. Butcher, and B. Corrin. 1993. Expression of tumor necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 22:343-347.
23. Piguet, P. F., C. Ribaux, V. Karpuz, G. E. Grau, and Y. Kapanci. 1993. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143:651-655.
24. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
25. Piguet, P. F., M. A. Collart, G. E. Grau, A. P. Sappino, and P. Vassalli. 1990. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245-247.
26. Piget, P. F., and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7:515-518
27. Fuchs, H. J., C. W. Czarniecki, H. H. Chiu, M. Sniezek, and J. E. Shellito. 1989. Interferon-gamma increases alveolar macrophage Ia antigen expression despite of oral administration of dexamethasone to rats. Am. J. Respir. Cell Mol. Biol. 1:525-532.
28. Hyde, D. M., T. S. Henderson, S. N. Giri, N. K. Tyler, and M. Y. Stovall. 1988. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp. Lung. Res. 14:687-704.
29. Nagafuji, K., T. Shibuya, M. Harada, S. Mizuno, K. Takenaka, T. Miyamato, T. Okamura, H. Gondo, and Y. Niho. 1995. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883-889.
30. Homma, S., I. Nagaoka, H. Abe, K. Takahashi, K. Seyama, T. Nukiwa, and S, Kira. 1995. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrolic lung. Am. J. Respir. Crit. Care Med. 152:2084-2089.
31. Nagaoka, I., B. C. Trapnell, and R. G. Crystal. 1990. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J. Clin. Invest. 85:2023-2027.
32. Aston, C., J. Jagirdar, T. C. Lee, T. Hur, R. L. Hintz, and W. N. Rom. 1995. Enhanced insulin-like growth factor molecule in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 151:1597-1603.
33. Maeda, A., K. Hiyama, H. Yamakido, S. Ishioka, and M. Yamakido. 1996. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BALF cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 109:780-786.
34. Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber. 1989. A receptor for immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341:758-760.
35. Liu, J., J. D. Farmer, Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
36. Flanagan, W. N., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803-807.
37. King, T. E., Jr. 1988. Idiopathic pulmonary lung fibrosis. In Interstitial Lung Diseases, M. I. Schwarz and T. E. King, Jr., editors. B. C. Decker, Inc., Philadelphia. 139-169.